Melodiol Delivers Another Record Quarter with ~$7.5M in Revenue Generated During Q3 FY/CY23, Up 265% on the PCP Psychedelics Investing
Seelos Therapeutics Retains Canaccord Genuity in Connection with Review of Potential Partnerships and Collaborations Psychedelics Investing
100%-Owned Subsidiary, Health House International Generates Quarterly Net Profit of +$300,000 from Australian Operations Psychedelics Investing
The Promise Of Psilocybin When It Comes To Mental Health, And How COMPASS Pathways Is Advancing It Psychedelics Investing
Wholly-Owned Subsidiary Halucenex Life Sciences Inc. Achieves Remission In 80% Of First Five Patients In Phase II Clinical Trial Cannabis Investing News
Goodness Growth Holdings and Grown Rogue International Announce the Completed Issuance of Warrants Psychedelics Investing
Melodiol Global Health: Global Portfolio of Strategic Cannabis and Plant-based Businesses Company News
COMPASS Pathways Is Accelerating Patient Access To Evidence-Based Innovation In Mental Health Care Psychedelics Investing
Seelos Therapeutics Announces Encouraging Data from an In Vivo Study of SLS-005 in an Aggressive Preclinical Model of Alzheimer's Disease Psychedelics Investing
How COMPASS Pathways Is Leveraging AI To Revolutionize The Mental Healthcare Space Psychedelics Investing
